» Authors » R C Leonard

R C Leonard

Explore the profile of R C Leonard including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 195
Citations 1060
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakr C, Symons J, Kreckmann K, Leonard R
Occup Environ Med . 2009 Jun; 66(10):699-703. PMID: 19553230
Objectives: Ammonium perfluorooctanoate (APFO) is a biopersistent surfactant used in the manufacture of several types of fluoropolymers. Based on previous findings of increased serum lipid levels associated with exposure to...
2.
Leonard R, Untch M, von Koch F
Ann Oncol . 2005 Apr; 16(5):817-24. PMID: 15817603
Many patients with breast cancer suffer from anaemia, as a consequence of the disease itself or its treatment. Anaemia has a negative impact on treatment outcome and overall survival, and...
3.
Dawson L, Leonard R
Breast . 2004 Feb; 8(3):149-51. PMID: 14965736
Skin-tunnelled catheters have become an accepted method for establishing long-term central venous access in patients undergoing treatment for malignancies. They allow administration of continuous infusions of cytotoxic drugs, supplementation of...
4.
Davidson K, Cameron D, Dillon P, Bowman A, Stewart M, Leonard R
Breast . 2004 Feb; 8(3):110-5. PMID: 14965725
Over a 5-year period, 75 patients with locally advanced breast cancer presenting to the Edinburgh Breast Unit were managed with a policy of infusional primary chemotherapy. For 65 patients, the...
5.
Dawson L, Nussey F, Oliver T, Marks R, Leonard R
Breast . 2004 Feb; 10(5):447-9. PMID: 14965623
We report a case of osteonecrosis in a patient treated with adjuvant chemotherapy for breast cancer. A 68-year-old woman presented with severe right hip pain. Seven months after completing a...
6.
Dixon J, Love C, Bellamy C, Cameron D, Leonard R, Smith H, et al.
Breast Cancer Res Treat . 2001 Aug; 66(3):191-9. PMID: 11510690
Aims: To investigate the efficacy of letrozole 2.5 mg and 10 mg used as primary neoadjuvant therapy for patients with locally advanced and large operable breast cancer. Patients And Methods:...
7.
Proctor S, Taylor P, Angus B, Wood K, Lennard A, Lucraft H, et al.
Eur J Haematol Suppl . 2001 Aug; 64:28-32. PMID: 11486397
One hundred and seven patients (61 with diffuse large B-cell non-Hodgkin's lymphomas and 46 with Hodgkin's disease) in relapse or following of primary therapy received ifosfamide 3 g/m2 i.v. daily...
8.
Acquavella J, Leonard R
Chem Biol Interact . 2001 Jun; 135-136:43-52. PMID: 11397380
Butadiene epidemiologic research has focused primarily on one cohort of workers in the North American styrene-butadiene rubber (SBR) industry and on the largest cohort of workers in the United States...
9.
Leonard R
Br J Cancer . 2001 Jun; 84(11):1437-42. PMID: 11384089
Although drugs such as the taxoids and vinorelbine have increased the options available for anthracycline-resistant metastatic breast cancer, new therapeutic options are needed, particularly for taxoid-refractory tumours. Increasing emphasis is...
10.
Donnellan P, Douglas S, Cameron D, Leonard R
J Clin Oncol . 2001 May; 19(10):2767. PMID: 11352973
No abstract available.